Stay updated on Tideglusib in Congenital Myotonic Dystrophy Clinical Trial

Sign up to get notified when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:12:59.000Z thumbnail image
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the weight-adjusted dose of 1000 mg/day tideglusib versus placebo in the treatment of children and adolescents aged 6-16 years with Congenital Myotonic Dystrophy (Congenital DM1). This change reflects a modification in the ongoing randomized, double-blind, placebo-controlled study for evaluating the efficacy and safety of Tideglusib in this patient population.
    Difference
    0.1%
    Check dated 2024-06-06T14:19:21.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying that researchers are looking for children and adolescents aged 6 to 16 years with a diagnosis of Congenital DM1. The criteria now include specific health conditions and prior treatments required for participation.
    Difference
    24%
    Check dated 2024-05-22T20:54:06.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:32:33.000Z thumbnail image

Stay in the know with updates to Tideglusib in Congenital Myotonic Dystrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tideglusib in Congenital Myotonic Dystrophy Clinical Trial page.